ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Vermont » Internal Medicine

Top Internal Medicine Prescribers in Vermont

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
STEPHEN GORMAN M.D.

Internal Medicine

436

$118K

98
52 are 65+

0%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 7%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

12%
prescriptions for brand name drugs

Avg: 22%

$271
Average prescription price

Avg: $63

KATHERINE DEVINE MD

Internal Medicine

3,161

$159K

201
149 are 65+

12%
patients receiving schedule two controlled substances

Avg: 10%

11%
patients receiving schedule three controlled substances

Avg: 7%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$50
Average prescription price

Avg: $63

PAMELA PEDERSEN M.D,

Internal Medicine

6,702

$337K

259
174 are 65+

9%
patients receiving schedule two controlled substances

Avg: 10%

16%
patients receiving schedule three controlled substances

Avg: 7%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$50
Average prescription price

Avg: $63

PETER DALE MD

Internal Medicine

8,327

$412K

359
304 are 65+

9%
patients receiving schedule two controlled substances

Avg: 10%

10%
patients receiving schedule three controlled substances

Avg: 7%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$49
Average prescription price

Avg: $63

LAURA FELSTED DO

Internal Medicine

4,861

$257K

316
256 are 65+

9%
patients receiving schedule two controlled substances

Avg: 10%

11%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$53
Average prescription price

Avg: $63

MARK HAMILTON M.D.

Internal Medicine

12,507

$574K

737
551 are 65+

15%
patients receiving schedule two controlled substances

Avg: 10%

7%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 22%

$46
Average prescription price

Avg: $63

JOHN DICK MD

Internal Medicine

7,711

$423K

352
275 are 65+

6%
patients receiving schedule two controlled substances

Avg: 10%

3%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$55
Average prescription price

Avg: $63

TEIG MARCO M.D.

Internal Medicine

13,856

$803K

452
382 are 65+

17%
patients receiving schedule two controlled substances

Avg: 10%

8%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$58
Average prescription price

Avg: $63

TIMOTHY TANNER MD

Internal Medicine

6,298

$394K

262
196 are 65+

15%
patients receiving schedule two controlled substances

Avg: 10%

11%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$63
Average prescription price

Avg: $63

MARK PITCHER M.D.

Internal Medicine

9,192

$584K

450
381 are 65+

15%
patients receiving schedule two controlled substances

Avg: 10%

8%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$63
Average prescription price

Avg: $63

NICOLE BELANGER MD

Internal Medicine

2,832

$179K

198
158 are 65+

10%
patients receiving schedule two controlled substances

Avg: 10%

17%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$63
Average prescription price

Avg: $63

BRIAN KILPATRICK MD

Internal Medicine

4,333

$292K

257
194 are 65+

7%
patients receiving schedule two controlled substances

Avg: 10%

5%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 22%

$67
Average prescription price

Avg: $63

ROBERT ROBINSON M.D.

Internal Medicine

8,780

$552K

320
238 are 65+

11%
patients receiving schedule two controlled substances

Avg: 10%

11%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$63
Average prescription price

Avg: $63

MICHAEL SCOVNER MD

Internal Medicine

6,966

$444K

305
211 are 65+

10%
patients receiving schedule two controlled substances

Avg: 10%

13%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$64
Average prescription price

Avg: $63

ROBERT TREMBLEY MD

Internal Medicine

12,237

$829K

360
284 are 65+

13%
patients receiving schedule two controlled substances

Avg: 10%

13%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 22%

$68
Average prescription price

Avg: $63

MARK JEWETT M.D.

Internal Medicine

3,926

$271K

164
121 are 65+

9%
patients receiving schedule two controlled substances

Avg: 10%

12%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$69
Average prescription price

Avg: $63

SETH COOMBS MD

Internal Medicine

7,451

$459K

369
317 are 65+

11%
patients receiving schedule two controlled substances

Avg: 10%

5%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 22%

$62
Average prescription price

Avg: $63

JOHN HUGHES MD

Internal Medicine

2,181

$127K

197
155 are 65+

7%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$58
Average prescription price

Avg: $63

MARLENE SACHS MD

Internal Medicine

3,488

$252K

212
173 are 65+

7%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$72
Average prescription price

Avg: $63

ROSEMARY DALE NP

Internal Medicine

885

$53.2K

138
98 are 65+

15%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$60
Average prescription price

Avg: $63

RICHARD BURTIS MD

Internal Medicine

2,003

$118K

251
198 are 65+

10%
patients receiving schedule two controlled substances

Avg: 10%

10%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$59
Average prescription price

Avg: $63

PETER GUNTHER M.D.

Internal Medicine

4,284

$469K

284
217 are 65+

15%
patients receiving schedule two controlled substances

Avg: 10%

13%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 22%

$109
Average prescription price

Avg: $63

PETER STICKNEY MD

Internal Medicine

11,924

$864K

428
368 are 65+

10%
patients receiving schedule two controlled substances

Avg: 10%

12%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 22%

$73
Average prescription price

Avg: $63

CHRISTOPHER RICKMAN MD

Internal Medicine

10,564

$921K

321
248 are 65+

7%
patients receiving schedule two controlled substances

Avg: 10%

10%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$87
Average prescription price

Avg: $63

MARILYN HART MD

Internal Medicine

3,277

$151K

186
169 are 65+

8%
patients receiving schedule two controlled substances

Avg: 10%

6%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$46
Average prescription price

Avg: $63

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank